What are the potential risks of antipsychotic medications?

What are the potential risks of antipsychotic medications?

• A. Allergic reactions only
• B. Extrapyramidal symptoms, tardive dyskinesia, and metabolic syndrome
• C. Nowhere near any serious side effects
• D. Only gastrointestinal disturbances

Answer: (B)

Antipsychotic medications, which are primarily used to treat schizophrenia and other serious mental health conditions, come with a range of potential risks that can significantly impact the patient's health. The correct answer highlights extrapyramidal symptoms, tardive dyskinesia, and metabolic syndrome as key risks associated with these medications. Extrapyramidal symptoms refer to drug-induced movement disorders that can include symptoms such as tremors, rigidity, and bradykinesia. These symptoms are linked to the effect of antipsychotics on dopamine pathways in the brain. Tardive dyskinesia is a serious and often irreversible side effect that involves involuntary, repetitive movements, usually of the face and mouth. It can occur after long-term use of antipsychotics, particularly older (typical) antipsychotics, and can lead to significant functional impairment and distress. Metabolic syndrome includes a cluster of conditions — such as obesity, increased blood pressure, high blood sugar levels, and dyslipidemia — which can increase the risk of heart disease and diabetes. Certain second-generation (atypical) antipsychotics are particularly associated with weight gain and metabolic alterations. The other choices do not accurately encapsulate the broader range of potential risks.

Antipsychotic medications, which are primarily used to treat schizophrenia and other serious mental health conditions, come with a range of potential risks that can significantly impact the patient's health. The correct answer highlights extrapyramidal symptoms, tardive dyskinesia, and metabolic syndrome as key risks associated with these medications.

Extrapyramidal symptoms refer to drug-induced movement disorders that can include symptoms such as tremors, rigidity, and bradykinesia. These symptoms are linked to the effect of antipsychotics on dopamine pathways in the brain.

Tardive dyskinesia is a serious and often irreversible side effect that involves involuntary, repetitive movements, usually of the face and mouth. It can occur after long-term use of antipsychotics, particularly older (typical) antipsychotics, and can lead to significant functional impairment and distress.

Metabolic syndrome includes a cluster of conditions — such as obesity, increased blood pressure, high blood sugar levels, and dyslipidemia — which can increase the risk of heart disease and diabetes. Certain second-generation (atypical) antipsychotics are particularly associated with weight gain and metabolic alterations.

The other choices do not accurately encapsulate the broader range of potential risks.